We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$98.6B
AUM Growth
+$9.82B
(+11%)
Cap. Flow
+$3.18B
Cap. Flow
% of AUM
3.23%
Top 10 Holdings %
Top 10 Hldgs %
34.51%
Holding
3,532
New
899
Increased
935
Reduced
953
Closed
698
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.93B |
| 2 |
Microsoft
MSFT
|
+$556M |
| 3 |
Cencora
COR
|
+$492M |
| 4 |
Netflix
NFLX
|
+$452M |
| 5 |
Bank of America
BAC
|
+$411M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$636M |
| 2 |
Eli Lilly
LLY
|
+$572M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$502M |
| 4 |
Advanced Micro Devices
AMD
|
+$395M |
| 5 |
CRH
CRH
|
+$379M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.19% |
| 2 | Consumer Discretionary | 12.64% |
| 3 | Healthcare | 9.35% |
| 4 | Financials | 8.34% |
| 5 | Communication Services | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Energy Recovery
ERII
$439M
| $3.69M | ﹤0.01% |
239,389
+189,175
| +377% | +$2.67M |
|
1302
Sonoco
SON
$5.8B
| $3.69M | ﹤0.01% |
85,581
+44,294
| +107% | +$2.05M |
|
1303
TriplePoint Venture Growth BDC
TPVG
$182M
| $3.67M | ﹤0.01% |
636,114
+106,913
| +20% | +$711K |
|
1304
Snowflake
SNOW
$94.6B
| $3.67M | ﹤0.01% |
16,273
+13,060
| +406% | +$2.8M |
|
|
GRDN
1305
Guardian Pharmacy Services
GRDN
$2.63B
| $3.67M | ﹤0.01% |
139,897
+124,455
| +806% | +$2.97M |
|
1306
Invesco QQQ Trust
QQQ
$449B
| $3.67M | ﹤0.01% |
+6,107
| New | +$3.5M |
|
1307
Vitesse Energy
VTS
$636M
| $3.63M | ﹤0.01% |
+156,323
| New | +$3.84M |
|
1308
Lattice Semiconductor
LSCC
$16.8B
| $3.62M | ﹤0.01% |
49,339
+37,875
| +330% | +$2.3M |
|
1309
StoneX
SNEX
$8.85B
| $3.62M | ﹤0.01% |
80,613
-20,734
| -20% | -$880K |
|
1310
Praxis Precision Medicines
PRAX
$8.8B
| $3.61M | ﹤0.01% |
+68,141
| New | +$3.3M |
|
1311
Rogers Communications
RCI
$17.7B
| $3.61M | ﹤0.01% |
104,697
+67,518
| +182% | +$2.32M |
|
1312
Match Group
MTCH
$9.05B
| $3.61M | ﹤0.01% |
+102,113
| New | +$3.64M |
|
|
XYF
1313
X Financial
XYF
$192M
| $3.6M | ﹤0.01% |
+261,750
| New | +$4.03M |
|
1314
Syndax Pharmaceuticals
SNDX
$1.82B
| $3.6M | ﹤0.01% |
233,973
+1,850
| +0.8% | +$24.2K |
|
1315
V2X
VVX
$2.73B
| $3.6M | ﹤0.01% |
61,919
+50,456
| +440% | +$2.7M |
|
1316
Warner Music
WMG
$14.4B
| $3.59M | ﹤0.01% |
105,509
-391,060
| -79% | -$12.5M |
|
1317
Upwork
UPWK
$1.14B
| $3.58M | ﹤0.01% |
192,830
+35,218
| +22% | +$525K |
|
1318
Golub Capital BDC
GBDC
$3.36B
| $3.58M | ﹤0.01% |
+261,417
| New | +$3.85M |
|
|
HPP
1319
Hudson Pacific Properties
HPP
$794M
| $3.58M | ﹤0.01% |
185,142
-95,405
| -34% | -$1.8M |
|
|
CTLP
1320
DELISTED
Cantaloupe
CTLP
| $3.56M | ﹤0.01% |
336,463
+272,635
| +427% | +$2.97M |
|
1321
Lincoln Educational Services
LINC
$1.29B
| $3.55M | ﹤0.01% |
+151,108
| New | +$3.24M |
|
1322
Customers Bancorp
CUBI
$2.66B
| $3.55M | ﹤0.01% |
54,299
+9,172
| +20% | +$603K |
|
1323
Bio-Rad Laboratories Class A
BIO
$8.47B
| $3.54M | ﹤0.01% |
12,614
+11,688
| +1,262% | +$3.18M |
|
|
SA
1324
Seabridge Gold
SA
$2.82B
| $3.53M | ﹤0.01% |
145,976
-395,910
| -73% | -$6.85M |
|
1325
CytomX Therapeutics
CTMX
$708M
| $3.52M | ﹤0.01% |
1,104,993
-1,248,129
| -53% | -$2.81M |
|
Similar funds
Marshall Wace's Q3 2025 Portfolio in Review
As of Q3 2025, Marshall Wace held 3,532 positions worth $98.6B, up 11% from $88.8B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $3.18B of net new capital in Q3 2025, opening 899 new positions and adding to 935 existing holdings. Its largest new stake was Texas Instruments: 1,537,539 shares worth $282M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $636M trimmed.
- Marshall Wace's largest Q3 2025 buy was Texas Instruments: 1,537,539 shares worth $282M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q3 2025, an estimated $3.93B increase.
- Marshall Wace's biggest Q3 2025 reduction was Alphabet (Google) Class A, cutting an estimated $636M.
- Marshall Wace fully exited AT&T in Q3 2025, selling an estimated $235M.
- Marshall Wace's ten largest holdings make up 35% of its $98.6B portfolio in Q3 2025.
- Marshall Wace opened 899 new positions and closed 698 in Q3 2025.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $98.6B.
Based on Marshall Wace's 13F filing for Q3 2025, filed 13 Nov 2025.